Physician profile
John Sherrill
NPI 1386639300
$1,163.21
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $376.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $279.32 | 2019-2020 | |
| Amgen INC. | $199.06 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.95 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $94.46 | 2019 | |
| Janssen Pharmaceuticals, INC | $85.38 | 2019-2020 | |
| Mylan Specialty L.P. | $69.96 | 2020 | |
| Abbvie INC. | $51.91 | 2020 | |
| Allergan, INC. | $47.91 | 2019-2020 | |
| Pfizer INC. | $31.50 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $30.50 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.68 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.22 | 2019 | |
| Biodelivery Sciences International, INC. | $15.47 | 2019 | |
| Eisai INC. | $11.51 | 2020 | |
| Amarin Pharma, INC. | $11.38 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sherrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.